Fast recovery of cardiac function in PIMS-TS patients early using intravenous anti-IL-1 treatment
Maria Vincenza Mastrolia, Edoardo Marrani, Giovanni Battista Calabri, Manuela L’Erario, Ilaria Maccora, Silvia Favilli, Pier Paolo Duchini, Ilaria Pagnini, Gabriele Simonini
Abstract
In our clinical practice, we adopted the early use of intravenous ANA for the treatment of cardiac disfunction in Pediatric Inflammatory Multisystem Syndrome tem- porally associated with SARS CoV-2 infection (PIMS-TS) patients. During the second COVID-19 wave, 9 PIMS-TS children were admitted to Meyer Children’s University Hospital in Florence (mean age of 10.2 y [IQR] 8.5–13). Echocardiography revealed a left ventricular ejection fraction (LVEF)≤40% in 5/9 patients
Topics & Concepts
MedicineCardiac function curveIntensive care medicineAnesthesiaEmergency medicinePharmacologyInternal medicineHeart failureKawasaki Disease and Coronary ComplicationsCardiac Structural Anomalies and RepairCoronary Artery Anomalies